Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Karolinska Institutet
With
Region Stockholm
The Swedish School of Sport and Health Sciences
Linkoeping University
Age
65–79
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Woman, 65-79 years old.
Vaccinated against Covid-19.
Be able to participate in nine months of training.
Untreated with Osteoporosis-medications, or have an ongoing treatment since at least one year back.
You may not be if
Ongoing treatment with Osteoporosis-medications with an onset within a year, or a previous treatment which was terminated within the last five years.
Ongoing treatment with Osteoporosis-medications that has been delayed for more than eight months for Denosumab, or more than 18 months for bisphosphonates.
Vertebral fracture, that have been diagnosed within three months.
Vertebral fracture or hip fracture, that have not previously been treated with Osteoporosis-medications or been assessed by a physician.
Bilateral hip replacements.
Symptomatic disc herniation, inguinal herniation or umbilical herniation.
Untreated hypertension.
Other diseases that can affect the results and participation in the study: malignant diseases, muscle dystrophy, secondary osteoporosis, or other conditions that would hinder study participation.
Ongoing treatment with oral cortisone pills (≥ 5 mg Prednisolone).
Conditions that hinders the conduction of impact microindentation with OsteoProbe: large edema, skin infection, allergy towards local anaesthetics.
Ongoing or previous training (within the last year) at OsteoStrong.
